Nile Pharmaceuticals

مادة اعلانية

Latest Update: 27 July 2025 15:25 Abu Dhabi Time.

Market Status: Closed

NIPH

Nile Pharmaceuticals

61.50

EGP

-1.220

-1.94%

Open

62.72

Prev Close

62.72

PX_VOLUME

56,275

MARKET CAP (M)

DAY RANGE

61.50 - 63.89

52 WEEKS

25.86 - 75.30

Stock Statistics

Yearly Change

121.53%

Listed Shares (Million)

30.00

Earnings Multiple

21.69

Average 30-day trading volume

90,288.67

Price-to-book ratio

2.54

Earnings Per Share

3.55

Previous Dividend Distribution

3.52

Dividend Yield

7.75%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue			121.77	79.23	296.69	387.93	378.73
Gross Profit			34.81	-22.98	66.54	99.51	109.37
Operating Income			12.05	-45.43	42.77	64.98	81.19
Profit Margin			-9.64	-40.59	8.89	10.87	14.22

	Period Ending:	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		1,142.58	1,005.22	876.78	755.51
Gross Profit		252.43	271.81	222.34	201.08
Operating Income		143.52	162.76	125.44	95.60
Profit Margin		7.90	11.86	10.23	8.53

Balance Sheet

	Period Ending:	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,985.65	1,568.73	1,473.19	1,420.28	1,201.86	1,106.13
Total Liabilities		1,243.43	1,111.61	1,004.34	905.13	710.54	573.80
Total Equity		742.22	457.12	468.86	515.14	491.33	532.32

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.